First and only steerable delivery system designed to help seal the left atrial appendage (LAA) in people with atrial fibrillation who are at an increased risk of stroke Now available in the U.S., ...
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global structural heart disease treatment devices market since 2018 and the market is poised to grow by USD 5.61 billion during 2020-2024 at ...
Abbott Laboratories continues to push its presence in the cardiovascular market with offerings for the left atrial appendage (LAA) closure and transcatheter aortic valve implant (TAVI) markets, both ...
Rochester, MN - A case report of a patient who suffered erosion of an Amplatzer septal-occluder device (St Jude Medical) six years after it was implanted, resulting in cardiac tamponade and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback